Prevalence of comorbid anxiety disorders in schizophrenia
- PMID: 28163406
- PMCID: PMC5248417
- DOI: 10.4103/0972-6748.196045
Prevalence of comorbid anxiety disorders in schizophrenia
Abstract
Background: Diagnostic and treatment hierarchical reductionisms have resulted in an oversight of anxiety syndromes in schizophrenia.
Aim: The aim of this study was to find the prevalence of different anxiety disorders in schizophrenia patients.
Materials and methods: The study was conducted on inpatients of a tertiary care psychiatric hospital using a prospective, purposive sampling technique. The study consisted of 93 schizophrenia patients and a similar number of normal controls. The schizophrenia patients and controls were evaluated for psychopathology and the presence of anxiety disorder.
Results: The prevalence of anxiety disorder was significantly higher in schizophrenia patients (45.16%) compared to controls (16.12%). Further, the prevalence of panic disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD) was significantly higher in schizophrenia patients. No significant correlation was observed between anxiety disorder scores and psychopathology scores.
Conclusions: The prevalence of comorbid anxiety disorders (panic disorder, social anxiety disorder, and OCD) in schizophrenia is significantly higher in the general population. The onset of anxiety disorder commonly precedes the onset of schizophrenia.
Keywords: Comorbid anxiety disorders; obsessive-compulsive disorder; panic disorder; schizophrenia; social anxiety disorder.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Correlates and management of comorbid anxiety disorders in schizophrenia.Ind Psychiatry J. 2018 Jul-Dec;27(2):271-278. doi: 10.4103/ipj.ipj_66_17. Ind Psychiatry J. 2018. PMID: 31359983 Free PMC article.
-
The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.Br J Clin Psychol. 2013 Sep;52(3):300-15. doi: 10.1111/bjc.12016. Epub 2013 Jan 18. Br J Clin Psychol. 2013. PMID: 23865406
-
Prevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorder.Int J Psychiatry Clin Pract. 2014 Oct;18(4):248-54. doi: 10.3109/13651501.2014.959972. Epub 2014 Oct 7. Int J Psychiatry Clin Pract. 2014. PMID: 25289805
-
Anxiety comorbidity in schizophrenia.Psychiatry Res. 2013 Nov 30;210(1):1-7. doi: 10.1016/j.psychres.2013.07.030. Epub 2013 Aug 7. Psychiatry Res. 2013. PMID: 23932838 Review.
-
Anxiety disorders in schizophrenia.Compr Psychiatry. 2004 Nov-Dec;45(6):460-8. doi: 10.1016/j.comppsych.2004.07.009. Compr Psychiatry. 2004. PMID: 15526257 Review.
Cited by
-
Impact of Childhood Trauma and Adult Separation Anxiety Disorder on Quality of Life in Individuals with Schizophrenia.Neuropsychiatr Dis Treat. 2023 Jan 23;19:181-196. doi: 10.2147/NDT.S391897. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 36714165 Free PMC article.
-
The Prevalence and Correlates of Social Anxiety Symptoms among People with Schizophrenia in Ethiopia: An Institution-Based Cross-Sectional Study.Schizophr Res Treatment. 2020 Mar 24;2020:3934680. doi: 10.1155/2020/3934680. eCollection 2020. Schizophr Res Treatment. 2020. PMID: 32274213 Free PMC article.
-
The Impact of THC and CBD in Schizophrenia: A Systematic Review.Front Psychiatry. 2021 Jul 23;12:694394. doi: 10.3389/fpsyt.2021.694394. eCollection 2021. Front Psychiatry. 2021. PMID: 34366924 Free PMC article.
-
A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia.Brain Sci. 2023 Nov 10;13(11):1577. doi: 10.3390/brainsci13111577. Brain Sci. 2023. PMID: 38002537 Free PMC article. Review.
-
Group Acceptance and Commitment Therapy for Recovery From Psychosis: Protocol for a Single-Group Waitlist Trial.JMIR Res Protoc. 2024 Mar 18;13:e49849. doi: 10.2196/49849. JMIR Res Protoc. 2024. PMID: 38498035 Free PMC article.
References
-
- Loga S, Loga-Zec S. Comorbidity in psychiatry: Its impact on psychopharmacological treatment. Psychiatr Danub. 2009;21:347–9. - PubMed
-
- Chaudhury S, Tikka SK, Bakhla AK. Impact of substance use disorder on presentation of schizophrenia. Dual Diagn. 2016;1:7.
-
- Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26:105–18. - PubMed
-
- Gray JA, Feldon J, Rawlings JN, Hemsley DR, Smith AD. The neuropsychology of schizophrenia. Behav Brain Sci. 1991;14:1–20.
-
- Bleuler E. In: Dementia praecox or the group of schizophrenias. Zinkin J, translator. New York: International Univesities Press; 1950.
LinkOut - more resources
Full Text Sources
Other Literature Sources